|
GTX14698
|
GeneTex International Corporation
|
Trident femto Western HRP Substrate
|
|
WB
|
|
|
GTX14698-S
|
GeneTex International Corporation
|
Trident femto Western HRP Substrate
|
|
WB
|
|
|
GTX17435
|
GeneTex International Corporation
|
Trident pico Western HRP Substrate
|
|
WB
|
|
|
GTX17435-S
|
GeneTex International Corporation
|
Trident pico Western HRP Substrate
|
|
WB
|
|
|
GTX27403
|
GeneTex International Corporation
|
Streptavidin (HRP)
|
|
Dot, ELISA, IHC-Fr, IHC-P, IM, WB
|
|
|
GTX30922
|
GeneTex International Corporation
|
ImmunoHistoMount
|
|
IHC
|
|
|
GTX30946
|
GeneTex International Corporation
|
TMBM (For Membranes)
|
|
WB
|
|
|
GTX30949
|
GeneTex International Corporation
|
Streptavidin (HRP)
|
|
ELISA, IHC, WB
|
|
|
GTX30967
|
GeneTex International Corporation
|
Endogenous peroxidase blocking kit
|
|
ICC/IF, IHC, IHC-P
|
|
|
HY-100002-10mg
|
MedChemexpress LLC
|
ML162 [CAS 1035072-16-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100002-100mg
|
MedChemexpress LLC
|
ML162 [CAS 1035072-16-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100002-25mg
|
MedChemexpress LLC
|
ML162 [CAS 1035072-16-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100002-5mg
|
MedChemexpress LLC
|
ML162 [CAS 1035072-16-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100002-50mg
|
MedChemexpress LLC
|
ML162 [CAS 1035072-16-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100003-10mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100003-5mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100003-50mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-10mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-100mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-2mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-25mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-5mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-50mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-112841-10mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
|
HY-112841-100mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
